MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma. Issue 8 (3rd July 2015) - Tabouret, Emeline; Boudouresque, Françoise; Farina, Patrizia; Barrié, Maryline; Bequet, Céline; Sanson, Marc; Chinot, Olivier